ARTICLE | Clinical News
Amphinex: Phase I/II started
February 10, 2014 8:00 AM UTC
PCI began an open-label, dose-escalation, European Phase I/II trial to compare a single treatment of Amphinex plus IV gemcitabine followed by gemcitabine plus IV cisplatin vs. gemcitabine plus cisplat...